FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2162491 · Received July 14, 2011

Report

Report Number
2124215-2011-07385
Event Type
Injury
Date Received
July 14, 2011
Date of Event
April 19, 2011
Report Date
June 29, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Additional Manufacturer Narrative · 1

VISUAL INSPECTION REVEALED THAT THE COMPLETE LEAD WAS RETURNED. THE PROXIMAL SHOCKING COIL WAS SEPARATED FROM THE MEDICAL ADHESIVE BONDING AT THE DISTAL END. THERE WERE MULTIPLE CUTS IN THE TRI-LUMAN INSULATION IN THE REGION OF 2832 CENTIMETERS FROM THE IS-1 PIN. THERE WAS DRIED BLOOD NOTED IN THE BASE AROUND THE HELIX AND THE HELIX WAS PHYSICALLY WITHIN SPECIFICATIONS. THE LEAD WAS CONFIRMED TO BE ECLECTICALLY CONTINUOUS. THE CLINICAL OBSERVATION OF DISLODGEMENT WAS UNABLE TO BE REPRODUCED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED DISLODGEMENT. THE PATIENT UNDERWENT A REVISION PROCEDURE. WHILE ATTEMPTING TO REPOSITION THIS LEAD THERE WAS DIFFICULTY EXPERIENCED WHEN TRYING TO ACTIVELY ENGAGE THE HELIX WITH THE PATIENT'S TISSUE. UPON REMOVAL OF THIS LEAD THERE WAS A CONSIDERABLE AMOUNT OF BLOOD/BODY FLUID AT THE TIP OF THE LEAD THAT WAS PREVENTING IT FROM RE-ENGAGING. A NEW LEAD WAS SUCCESSFULLY PLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION INDICATES THAT THIS PRODUCT WAS RETURNED FOR LABORATORY ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0184

Patients

Seq Age Sex Outcome Treatment
1 83 YR Required Intervention 0184| 4469| E110